Premium
A randomized double‐blind, placebo‐controlled study of combination estradiol/norethisterone acetate transdermal hormone replacement therapy (estalis® sequi) in a sequential regimen on menopausal vasomotor symptoms
Author(s) -
Notelovitz M.
Publication year - 2000
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(00)84632-9
Subject(s) - medicine , norethisterone , vasomotor , hormone replacement therapy (female to male) , norethisterone acetate , regimen , placebo , menopause , randomized controlled trial , hormone therapy , estrogen , double blind , gynecology , physical therapy , breast cancer , population , alternative medicine , testosterone (patch) , cancer , research methodology , environmental health , pathology